Yoshitaka Narita

38PUBLICATIONS
93CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Biomedical imagingCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Aug 21, 2026
Role of antiseizure medication in postoperative late seizure and survival among patients with newly diagnosed glioblastoma: A multicenter retrospective study.

|Jun 22, 2026
Possible involvement of genome-wide near-haploidy and MEN1 mutation in the molecular pathogenesis of pituitary carcinoma: Analysis by whole exome sequencing.

|Jun 18, 2026
A multicenter randomized phase II/III trial of salvage treatment for refractory primary central nervous system lymphoma using tirabrutinib: JCOG2314 (ReSTART).

|May 27, 2026
Prediction of Overall Survival in Glioblastoma Using Early Postoperative Reduction in FLAIR Lesion Volume After Gross Total Resection.

|Oct 13, 2025
Gross total resection is associated with improvement and prognosis even in von Hippel-Lindau disease-related hemangioblastomas: Nationwide registry in Japan.

Shunsaku Takayanagi, Fusao Ikawa, Hirokazu Takami

|Aug 15, 2025
Advance care planning in primary malignant brain tumors: Knowledge, experiences, and preferences of patients and caregivers.

Ai Chikada, Yoshiki Arakawa, Sayaka Takenouchi

Pageof 7

Frequent Collaborators

12 joint publications

Yoshiki Arakawa

10 joint publications

Makoto Ohno

10 joint publications

Motoo Nagane

5 joint publications

Ryo Nishikawa